{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:32:24Z","timestamp":1778452344201,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cld.2018.03.009","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T23:35:10Z","timestamp":1530747310000},"page":"589-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antimitochondrial Antibody\u2013Negative Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"22","author":[{"given":"David M.","family":"Chascsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.cld.2018.03.009_bib1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib2","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.clinre.2015.08.001","article-title":"Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'","volume":"39","author":"Beuers","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2018.03.009_bib4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.15.8.664","article-title":"Mitochondrial antibodies (AMA)","volume":"15","author":"Doniach","year":"1974","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.cld.2018.03.009_bib5","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","article-title":"Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis","volume":"21","author":"Nezu","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2018.03.009_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00296-005-0034-y","article-title":"The presence of anti-mitochondrial antibodies in Chinese patients with liver involvement in systemic lupus erythematosus","volume":"26","author":"Li","year":"2006","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.cld.2018.03.009_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1478-3231.2007.01651.x","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis","volume":"28","author":"Liu","year":"2008","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2018.03.009_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1478-3231.2005.01078.x","article-title":"Does the diagnosis of primary biliary cirrhosis of autoimmune cholangitis depend on the 'phase' of the disease?","volume":"25","author":"Kadokawa","year":"2005","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2018.03.009_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004836-199610000-00007","article-title":"Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis - atypical primary biliary cirrhosis or autoimmune cholangitis?","volume":"23","author":"SanchezPobre","year":"1996","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1\u20132","key":"10.1016\/j.cld.2018.03.009_bib10","first-page":"31","article-title":"Autoimmune cholangitis - AMA-negative syndrome","volume":"21","author":"Jesic","year":"2002","journal-title":"Arch Gastroenterohepatol"},{"issue":"12","key":"10.1016\/j.cld.2018.03.009_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cld.2018.03.009_bib12","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/0016-5085(95)90143-4","article-title":"Antibodies to carbonic anhydrase in patients with immune cholangiopathies","volume":"108","author":"Gordon","year":"1995","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib13","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2018.03.009_bib14","first-page":"247","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis","volume":"90","author":"Lacerda","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2018.03.009_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.35.2.260","article-title":"Antimitochondrial antibody negative primary biliary-cirrhosis - a distinct syndrome of autoimmune cholangitis","volume":"35","author":"Michieletti","year":"1994","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00000478-199401000-00009","article-title":"Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis","volume":"18","author":"Taylor","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0399-8320(07)89322-5","article-title":"Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status","volume":"31","author":"Alric","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"issue":"6","key":"10.1016\/j.cld.2018.03.009_bib18","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1155\/2005\/203028","article-title":"Characteristics of primary biliary cirrhosis in British Columbia's first nations population","volume":"19","author":"Arbour","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"39","key":"10.1016\/j.cld.2018.03.009_bib21","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3748\/wjg.v16.i39.4938","article-title":"Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients","volume":"16","author":"Sfakianaki","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2018.03.009_bib22","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib23","first-page":"30","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid","volume":"16","author":"Sakauchi","year":"2005","journal-title":"J\u00a0Epidemiol"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/PAS.0b013e31824b1dff","article-title":"Evaluation of Langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis","volume":"36","author":"Graham","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib25","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2018.03.009_bib26","first-page":"428","article-title":"Cytotoxic T-lymphocyte antigen 4 gene+49A\/G polymorphism significantly associated with susceptibility to primary biliary cirrhosis: a meta-analysis","volume":"12","author":"Chen","year":"2011","journal-title":"J\u00a0Dig Dis"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.23667","article-title":"Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction","volume":"52","author":"Juran","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2018.03.009_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaut.2010.06.005","article-title":"Update on the genetics and genomics of PBC","volume":"35","author":"Juran","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1590-8658(02)80059-7","article-title":"Familial primary biliary cirrhosis and autoimmune cholangitis","volume":"34","author":"Agarwal","year":"2002","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(01)00237-9","article-title":"Human leukocyte antigen class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis","volume":"36","author":"Stone","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib31","first-page":"1440","article-title":"Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis","volume":"22","author":"Tsuneyama","year":"1995","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.cld.2018.03.009_bib32","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/elps.201400342","article-title":"Serological comparative proteomics analysis of mitochondrial autoantibody-negative and -positive primary biliary cirrhosis","volume":"36","author":"Deng","year":"2015","journal-title":"Electrophoresis"},{"issue":"1\u20132","key":"10.1016\/j.cld.2018.03.009_bib33","first-page":"9","article-title":"Antimitochondrial antibodies - negative primary biliary cirrhosis - a variant of primary biliary cirrhosis","volume":"14","author":"Simionov","year":"2009","journal-title":"AFH"},{"issue":"6","key":"10.1016\/j.cld.2018.03.009_bib34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/00365521.2015.1132337","article-title":"Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis","volume":"51","author":"Juliusson","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2018.03.009_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0676.1997.tb01033.x","article-title":"Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies","volume":"17","author":"Nakanuma","year":"1997","journal-title":"Liver"},{"issue":"99\u2013100","key":"10.1016\/j.cld.2018.03.009_bib36","first-page":"441","article-title":"Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis","volume":"57","author":"Ozaslan","year":"2010","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1386-6346(00)00083-8","article-title":"Histopathologic comparison of anti-mitochondrial antibody-positive primary biliary cirrhosis and autoimmune cholangiopathy","volume":"19","author":"Watanabe","year":"2001","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib38","first-page":"323","article-title":"Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experience","volume":"26","author":"Tsou","year":"2003","journal-title":"Chang Gung Med J"},{"issue":"6","key":"10.1016\/j.cld.2018.03.009_bib39","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0016-5085(89)90526-X","article-title":"Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival","volume":"96","author":"Gores","year":"1989","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2018.03.009_bib40","first-page":"288","article-title":"Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis","volume":"3","author":"Zhang","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.clinre.2016.06.001","article-title":"The diagnosis of antimitochondrial antibody-negative primary biliary cholangitis","volume":"40","author":"Ozaslan","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5\u20136","key":"10.1016\/j.cld.2018.03.009_bib42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cca.2009.12.012","article-title":"Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis","volume":"411","author":"Liaskos","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"issue":"58","key":"10.1016\/j.cld.2018.03.009_bib44","first-page":"937","article-title":"No prognostic significance of antimitochondrial antibody profile testing in primary biliary cirrhosis","volume":"51","author":"Vleggaar","year":"2004","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2018.03.009_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/gut.22.2.136","article-title":"Is mitochondrial antibody diagnostic of primary biliary cirrhosis?","volume":"22","author":"Munoz","year":"1981","journal-title":"Gut"},{"issue":"15\u201316","key":"10.1016\/j.cld.2018.03.009_bib46","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cca.2012.03.020","article-title":"Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis","volume":"413","author":"Mytilinaiou","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.cld.2018.03.009_bib47","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s10620-011-1756-1","article-title":"Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis","volume":"56","author":"Hu","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.cld.2018.03.009_bib48","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","article-title":"Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature","volume":"42","author":"Bizzaro","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.cld.2018.03.009_bib49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.cld.2018.03.009_bib50","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2018.03.009_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-5926-10-9","article-title":"Autoimmune liver disease - are there spectra that we do not know?","volume":"10","author":"Fallatah","year":"2011","journal-title":"Comp Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2018.03.009_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10238-012-0207-4","article-title":"Clinical significance and prevalence of anti-Saccharomyces cerevisiae antibody in Chinese patients with primary biliary cirrhosis","volume":"13","author":"Hu","year":"2013","journal-title":"Clin Exp Med"},{"issue":"10","key":"10.1016\/j.cld.2018.03.009_bib53","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1023\/A:1005548126211","article-title":"Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?","volume":"45","author":"Comay","year":"2000","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2018.03.009_bib54","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.25511","article-title":"Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis","volume":"55","author":"Jin","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2018.03.009_bib55","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.1111\/j.1872-034X.2007.00246.x","article-title":"Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis","volume":"37","author":"Hashimoto","year":"2007","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.cld.2018.03.009_bib56","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.510260103","article-title":"Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation","volume":"26","author":"Kim","year":"1997","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2018.03.009_bib58","first-page":"334","article-title":"Clinical evaluation of primary biliary cirrhosis in Chinese patients without serum anti-mitochondrial antibody","volume":"59","author":"Li","year":"1997","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"issue":"1","key":"10.1016\/j.cld.2018.03.009_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2036.2003.01381.x","article-title":"Is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?","volume":"17","author":"Gisbert","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2018.03.009_bib60","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/jhep.2000.7878","article-title":"Autoimmune cholangitis within the spectrum of autoimmune liver disease","volume":"31","author":"Czaja","year":"2000","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2018.03.009_bib61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1089-3261(05)70085-4","article-title":"Autoimmune cholangiopathy","volume":"3","author":"Vierling","year":"1999","journal-title":"Clin Liver Dis"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T23:14:23Z","timestamp":1720394063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118300345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1089326118300345"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.03.009","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimitochondrial Antibody\u2013Negative Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}